DTL
IMCR icon

Dynamic Technology Lab’s Immunocore IMCR Stock Holding History

Dynamic Technology Lab’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,670
Closed -$280K – 1182
2023
Q1 		$280K Buy
+5,670
New +$319K 0.03% 814

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dynamic Technology Lab's IMCR Position: Q2 2023 in Review

Dynamic Technology Lab sold out of Immunocore (IMCR) in Q2 2023, closing a stake of 5,670 shares — an estimated $280K sold.

Dynamic Technology Lab first reported a position in IMCR in Q1 2023 and held it in 1 quarter. The position peaked at $280K in Q1 2023. 120 funds tracked by Wall St. Rank hold IMCR as of Q2 2023.

  • Dynamic Technology Lab reported no remaining Immunocore position as of Q2 2023 after selling out during the quarter.
  • Dynamic Technology Lab sold 5,670 Immunocore shares in Q2 2023, an estimated $280K.
  • Dynamic Technology Lab first reported a position in Immunocore in Q1 2023 and held it in 1 quarter.
  • Dynamic Technology Lab's Immunocore position peaked at $280K in Q1 2023.
  • 120 funds tracked by Wall St. Rank held Immunocore as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.